Sebastien Humbert

Metz, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Huntingtin as an Actin Organizer: Structural and Functional Insights.

Huntingtin as an Actin Organizer: Structural and Functional Insights.

Journal: Cytoskeleton (Hoboken, N.J.)

Published: April 22, 2026

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.

Journal: Journal of internal medicine

Published: November 24, 2025

Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis.

Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 20, 2025

Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-Up.

Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-Up.

Journal: Journal of inherited metabolic disease

Published: December 19, 2024

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: October 28, 2024

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Journal: American journal of hematology

Published: October 15, 2024

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.

Journal: Blood advances

Published: July 29, 2024

Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.

Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.

Journal: Annals of the rheumatic diseases

Published: June 28, 2024

A developmental component to Huntington's disease.

A developmental component to Huntington's disease.

Journal: Revue neurologique

Published: February 19, 2024

Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study.

Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study.

Journal: European journal of internal medicine

Published: December 17, 2023

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.

Journal: Annals of the rheumatic diseases

Published: August 07, 2023

Pregnancy outcome in patients with a medical history of immunoglobulin A vasculitis: a case-control study.

Pregnancy outcome in patients with a medical history of immunoglobulin A vasculitis: a case-control study.

Journal: Scandinavian journal of rheumatology

Published: July 13, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026